Lineage Cash And Short Term Investments from 2010 to 2024
| LCTX Stock | USD 0.61 0.04 7.02% |
Cash And Short Term Investments | First Reported 1992-03-31 | Previous Quarter 38.5 M | Current Value 32.7 M | Quarterly Volatility 18.9 M |
Check Lineage Cell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lineage Cell's main balance sheet or income statement drivers, such as Depreciation And Amortization of 922.5 K, Interest Expense of 6 M or Total Revenue of 9.4 M, as well as many indicators such as Price To Sales Ratio of 19.99, Dividend Yield of 0.0015 or PTB Ratio of 3.12. Lineage financial statements analysis is a perfect complement when working with Lineage Cell Valuation or Volatility modules.
Lineage | Cash And Short Term Investments |
Latest Lineage Cell's Cash And Short Term Investments Growth Pattern
Below is the plot of the Cash And Short Term Investments of Lineage Cell Therapeutics over the last few years. Short Term Investments is an account in the current assets section of Lineage Cell Therapeutics balance sheet. This account contains Lineage Cell investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Lineage Cell Therapeutics fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Lineage Cell's Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lineage Cell's overall financial position and show how it may be relating to other accounts over time.
| Cash And Short Term Investments | 10 Years Trend |
|
Cash And Short Term Investments |
| Timeline |
Lineage Cash And Short Term Investments Regression Statistics
| Arithmetic Mean | 30,815,123 | |
| Geometric Mean | 23,955,750 | |
| Coefficient Of Variation | 55.07 | |
| Mean Deviation | 12,800,631 | |
| Median | 30,741,000 | |
| Standard Deviation | 16,969,974 | |
| Sample Variance | 288T | |
| Range | 54M | |
| R-Value | 0.76 | |
| Mean Square Error | 131.8T | |
| R-Squared | 0.58 | |
| Significance | 0 | |
| Slope | 2,877,648 | |
| Total Sum of Squares | 4031.7T |
Lineage Cash And Short Term Investments History
About Lineage Cell Financial Statements
Lineage Cell investors use historical fundamental indicators, such as Lineage Cell's Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lineage Cell. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash And Short Term Investments | 35.5 M | 37.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Lineage Stock Analysis
When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.